Protagonist Therapeutics
Price & Volume
Stats
See more52W Range | $54.50-$155.53 |
Market Cap | $10B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $281.9M |
Revenue Growth (YoY) | 3,749.2% |
Gross Profit (12 Mos) | $281.9M |
Diluted EPS | $1.06 |
News
See moreYahoo Finance • 3 months ago
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
Yahoo Finance • 3 months ago
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
Yahoo Finance • 4 months ago
Protagonist Therapeutics Inc. (PTGX): Billionaire Joe Edelman Likes This Stock
Yahoo Finance • 4 months ago
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |